163 related articles for article (PubMed ID: 11473122)
1. Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives.
Leali D; Belleri M; Urbinati C; Coltrini D; Oreste P; Zoppetti G; Ribatti D; Rusnati M; Presta M
J Biol Chem; 2001 Oct; 276(41):37900-8. PubMed ID: 11473122
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists.
Presta M; Oreste P; Zoppetti G; Belleri M; Tanghetti E; Leali D; Urbinati C; Bugatti A; Ronca R; Nicoli S; Moroni E; Stabile H; Camozzi M; Hernandez GA; Mitola S; Dell'Era P; Rusnati M; Ribatti D
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):71-6. PubMed ID: 15514208
[TBL] [Abstract][Full Text] [Related]
3. Short heparin sequences spaced by glycol-split uronate residues are antagonists of fibroblast growth factor 2 and angiogenesis inhibitors.
Casu B; Guerrini M; Naggi A; Perez M; Torri G; Ribatti D; Carminati P; Giannini G; Penco S; Pisano C; Belleri M; Rusnati M; Presta M
Biochemistry; 2002 Aug; 41(33):10519-28. PubMed ID: 12173939
[TBL] [Abstract][Full Text] [Related]
4. Undersulfated and glycol-split heparins endowed with antiangiogenic activity.
Casu B; Guerrini M; Guglieri S; Naggi A; Perez M; Torri G; Cassinelli G; Ribatti D; Carminati P; Giannini G; Penco S; Pisano C; Belleri M; Rusnati M; Presta M
J Med Chem; 2004 Feb; 47(4):838-48. PubMed ID: 14761186
[TBL] [Abstract][Full Text] [Related]
5. Sulfated derivatives of Escherichia coli K5 polysaccharides as modulators of fibroblast growth factor signaling.
Borgenström M; Jalkanen M; Salmivirta M
J Biol Chem; 2003 Dec; 278(50):49882-9. PubMed ID: 14514688
[TBL] [Abstract][Full Text] [Related]
6. Heparan sulfate proteoglycans mediate the angiogenic activity of the vascular endothelial growth factor receptor-2 agonist gremlin.
Chiodelli P; Mitola S; Ravelli C; Oreste P; Rusnati M; Presta M
Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):e116-27. PubMed ID: 21921258
[TBL] [Abstract][Full Text] [Related]
7. Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists.
Urbinati C; Bugatti A; Oreste P; Zoppetti G; Waltenberger J; Mitola S; Ribatti D; Presta M; Rusnati M
FEBS Lett; 2004 Jun; 568(1-3):171-7. PubMed ID: 15196942
[TBL] [Abstract][Full Text] [Related]
8. Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis.
Rusnati M; Camozzi M; Moroni E; Bottazzi B; Peri G; Indraccolo S; Amadori A; Mantovani A; Presta M
Blood; 2004 Jul; 104(1):92-9. PubMed ID: 15031207
[TBL] [Abstract][Full Text] [Related]
9. The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an antiangiogenic multitarget fibroblast growth factor-2 antagonist.
Liekens S; Bronckaers A; Belleri M; Bugatti A; Sienaert R; Ribatti D; Nico B; Gigante A; Casanova E; Opdenakker G; Pérez-Pérez MJ; Balzarini J; Presta M
Mol Cancer Ther; 2012 Apr; 11(4):817-29. PubMed ID: 22302099
[TBL] [Abstract][Full Text] [Related]
10. Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds.
Liekens S; Leali D; Neyts J; Esnouf R; Rusnati M; Dell'Era P; Maudgal PC; De Clercq E; Presta M
Mol Pharmacol; 1999 Jul; 56(1):204-13. PubMed ID: 10385702
[TBL] [Abstract][Full Text] [Related]
11. Noncompetitive, chemokine-mediated inhibition of basic fibroblast growth factor-induced endothelial cell proliferation.
Presta M; Belleri M; Vecchi A; Hesselgesser J; Mantovani A; Horuk R
J Biol Chem; 1998 Apr; 273(14):7911-9. PubMed ID: 9525887
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived anti-angiogenic pentapeptide.
Leali D; Bianchi R; Bugatti A; Nicoli S; Mitola S; Ragona L; Tomaselli S; Gallo G; Catello S; Rivieccio V; Zetta L; Presta M
J Cell Mol Med; 2010 Aug; 14(8):2109-21. PubMed ID: 19627396
[TBL] [Abstract][Full Text] [Related]
13. Highly sulfated K5 Escherichia coli polysaccharide derivatives inhibit respiratory syncytial virus infectivity in cell lines and human tracheal-bronchial histocultures.
Cagno V; Donalisio M; Civra A; Volante M; Veccelli E; Oreste P; Rusnati M; Lembo D
Antimicrob Agents Chemother; 2014 Aug; 58(8):4782-94. PubMed ID: 24914125
[TBL] [Abstract][Full Text] [Related]
14. Endothelial heparan sulfate 6-O-sulfation levels regulate angiogenic responses of endothelial cells to fibroblast growth factor 2 and vascular endothelial growth factor.
Ferreras C; Rushton G; Cole CL; Babur M; Telfer BA; van Kuppevelt TH; Gardiner JM; Williams KJ; Jayson GC; Avizienyte E
J Biol Chem; 2012 Oct; 287(43):36132-46. PubMed ID: 22927437
[TBL] [Abstract][Full Text] [Related]
15. Sulfated K5 Escherichia coli polysaccharide derivatives as wide-range inhibitors of genital types of human papillomavirus.
Lembo D; Donalisio M; Rusnati M; Bugatti A; Cornaglia M; Cappello P; Giovarelli M; Oreste P; Landolfo S
Antimicrob Agents Chemother; 2008 Apr; 52(4):1374-81. PubMed ID: 18250186
[TBL] [Abstract][Full Text] [Related]
16. Broad spectrum inhibition of HIV-1 infection by sulfated K5 Escherichia coli polysaccharide derivatives.
Vicenzi E; Gatti A; Ghezzi S; Oreste P; Zoppetti G; Poli G
AIDS; 2003 Jan; 17(2):177-81. PubMed ID: 12545076
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy.
Rezzola S; Dal Monte M; Belleri M; Bugatti A; Chiodelli P; Corsini M; Cammalleri M; Cancarini A; Morbidelli L; Oreste P; Bagnoli P; Semeraro F; Presta M
Diabetes; 2015 Jul; 64(7):2581-92. PubMed ID: 25695948
[TBL] [Abstract][Full Text] [Related]
18. Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway.
Sulpice E; Bryckaert M; Lacour J; Contreres JO; Tobelem G
Blood; 2002 Nov; 100(9):3087-94. PubMed ID: 12384403
[TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic activity of a neutralizing human single-chain antibody fragment against fibroblast growth factor receptor 1.
Ronca R; Benzoni P; Leali D; Urbinati C; Belleri M; Corsini M; Alessi P; Coltrini D; Calza S; Presta M; Dell'Era P
Mol Cancer Ther; 2010 Dec; 9(12):3244-53. PubMed ID: 20940322
[TBL] [Abstract][Full Text] [Related]
20. Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2.
Ribatti D; Gualandris A; Belleri M; Massardi L; Nico B; Rusnati M; Dell'Era P; Vacca A; Roncali L; Presta M
J Pathol; 1999 Dec; 189(4):590-9. PubMed ID: 10629563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]